3.865

6.18% 0.225

Rocket Pharmaceuticals Inc (RCKT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$3.64

Aprire:

$3.68

Volume 24 ore:

1.99M

Relative Volume:

0.61

Capitalizzazione di mercato:

$421.76M

Reddito:

Utile/perdita netta:

$-223.12M

Rapporto P/E:

-1.9234

EPS:

-2.0095

Flusso di cassa netto:

$-190.49M

1 W Prestazione:

+7.36%

1M Prestazione:

-18.29%

6M Prestazione:

-8.84%

1 anno Prestazione:

-40.81%

Intervallo 1D:

$3.68

$3.88

Intervallo di 1 settimana:

$3.46

$3.88

Portata 52W:

$2.19

$8.26

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Nome

Rocket Pharmaceuticals Inc

Settore

Healthcare (1118)

Industria

Biotechnology (622)

Telefono

646-440-9100

Indirizzo

350 FIFTH AVENUE, NEW YORK, NY

Dipendente

202

Cinguettio

@rocketpharma

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

RCKT's Discussions on Twitter

Compare RCKT vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
RCKT Rocket Pharmaceuticals Inc	3.865	397.21M	0	-223.12M	-190.49M	-2.0095
VRTX Vertex Pharmaceuticals Inc	442.30	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	754.22	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	841.25	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	334.93	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	320.05	34.41B	5.36B	287.73M	924.18M	2.5229

Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-18	Downgrade	JP Morgan	Neutral → Underweight
2025-08-20	Aggiornamento	BofA Securities	Neutral → Buy
2025-07-25	Downgrade	BofA Securities	Buy → Neutral
2025-05-30	Downgrade	Evercore ISI	Outperform → In-line
2025-05-28	Downgrade	Goldman	Neutral → Sell
2025-05-28	Downgrade	JP Morgan	Overweight → Neutral
2025-05-28	Downgrade	Jefferies	Buy → Hold
2025-05-28	Downgrade	Leerink Partners	Outperform → Market Perform
2025-05-28	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2025-05-27	Downgrade	Needham	Buy → Hold
2025-05-27	Downgrade	TD Cowen	Buy → Hold
2025-03-12	Iniziato	BMO Capital Markets	Outperform
2024-12-30	Iniziato	Wedbush	Outperform
2024-12-18	Iniziato	Jefferies	Buy
2024-10-16	Iniziato	Scotiabank	Sector Outperform
2024-04-02	Iniziato	Goldman	Neutral
2023-10-24	Iniziato	Cantor Fitzgerald	Overweight
2023-02-01	Iniziato	Morgan Stanley	Overweight
2022-11-08	Iniziato	Canaccord Genuity	Buy
2022-11-01	Iniziato	BTIG Research	Buy
2022-07-08	Iniziato	Raymond James	Outperform
2021-10-20	Ripresa	Cowen	Outperform
2021-03-02	Iniziato	Stifel	Buy
2021-02-18	Iniziato	Needham	Buy
2020-12-16	Iniziato	UBS	Buy
2020-12-08	Downgrade	Oppenheimer	Outperform → Perform
2020-07-02	Iniziato	JP Morgan	Overweight
2020-06-25	Ripresa	BofA/Merrill	Buy
2020-06-01	Ripresa	Oppenheimer	Outperform
2019-11-06	Iniziato	Chardan Capital Markets	Buy
2019-09-26	Iniziato	Piper Jaffray	Overweight
2019-04-23	Iniziato	Robert W. Baird	Outperform
2019-03-15	Iniziato	BofA/Merrill	Buy
2019-02-05	Iniziato	Oppenheimer	Outperform
2018-09-13	Iniziato	Ladenburg Thalmann	Buy
2018-07-10	Iniziato	William Blair	Outperform

Mostra tutto

Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie

07:46 AM

Needham Maintains Rocket Pharmaceuticals(RCKT.US) With Hold Rating - Moomoo

07:46 AM

Apr 13, 2026

Activity Recap: Is Rocket Pharmaceuticals Inc Equity Warrant a cyclical or defensive stock2026 News Drivers & Consistent Return Strategy Ideas - baoquankhu1.vn

Apr 13, 2026

Meme Stocks: Can Rocket Pharmaceuticals Inc expand into new markets2026 News Drivers & Stepwise Trade Execution Plans - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

Big Picture: Will Rocket Pharmaceuticals Inc benefit from sector rotationQuarterly Portfolio Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn

Apr 12, 2026

Apr 10, 2026

RCKT stock dives despite gene therapy approval — Wall Street dismisses sell-off - MSN

Apr 10, 2026

Volume Report: Can Rocket Pharmaceuticals Inc deliver consistent EPS growth2026 Stock Rankings & AI Forecast Swing Trade Picks - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Aug Ideas: Is Rocket Pharmaceuticals Inc exposed to political risk2026 Winners & Losers & AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

RCKT Technical Analysis | Trend, Signals & Chart Patterns | ROCKET PHARMACEUTICALS INC (NASDAQ:RCKT) - ChartMill

Apr 08, 2026

Apr 06, 2026

[ARS] ROCKET PHARMACEUTICALS, INC. SEC Filing - Stock Titan

Apr 06, 2026

Rocket Pharmaceuticals (NASDAQ: RCKT) seeks vote on director slate and option exchange - Stock Titan

Apr 06, 2026

Apr 05, 2026

Rally Mode: Is Rocket Pharmaceuticals Inc stock a good dividend stockPrice Action & Technical Confirmation Alerts - baoquankhu1.vn

Apr 05, 2026

Apr 03, 2026

US premarket movers: Argan, Rocket Pharmaceuticals, Unity - MSN

Apr 03, 2026

Rocket gene therapy, among FDA’s March approvals, earns PRV - biocentury.com

Apr 03, 2026

[SC TO-C] ROCKET PHARMACEUTICALS, INC. Tender Offer Communication | RCKT SEC FilingForm SC TO-C - Stock Titan

Apr 03, 2026

FDA Grants Accelerated Approval to Rocket Pharma’s Gene Therapy Kresladi for LAD-I - The Indian Practitioner

Apr 03, 2026

Apr 02, 2026

RCKTW SEC FilingsROCKET PHARMACEUTICALS INC 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 02, 2026

Rocket Pharmaceuticals Inc (9IP1.DU) valuation measures and financial statistics - Yahoo Finance UK

Apr 02, 2026

First Therapy Funded by California Taxpayer Dollars is Approved to Treat Rare Childhood Disorder - Noticias Newswire

Apr 02, 2026

Momentum Shift: What are Rocket Pharmaceuticals Incs growth levers2026 Action & Fast Entry High Yield Tips - baoquankhu1.vn

Apr 02, 2026

Apr 01, 2026